• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨诱导的c-kit在前列腺癌中的表达:骨内肿瘤生长的驱动因素。

Bone-induced c-kit expression in prostate cancer: a driver of intraosseous tumor growth.

作者信息

Mainetti Leandro E, Zhe Xiaoning, Diedrich Jonathan, Saliganan Allen D, Cho Won Jin, Cher Michael L, Heath Elisabeth, Fridman Rafael, Kim Hyeong-Reh Choi, Bonfil R Daniel

机构信息

Department of Urology, Wayne State University School of Medicine, Detroit, MI.

出版信息

Int J Cancer. 2015 Jan 1;136(1):11-20. doi: 10.1002/ijc.28948. Epub 2014 May 20.

DOI:10.1002/ijc.28948
PMID:24798488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4199873/
Abstract

Loss of BRCA2 function stimulates prostate cancer (PCa) cell invasion and is associated with more aggressive and metastatic tumors in PCa patients. Concurrently, the receptor tyrosine kinase c-kit is highly expressed in skeletal metastases of PCa patients and induced in PCa cells placed into the bone microenvironment in experimental models. However, the precise requirement of c-kit for intraosseous growth of PCa and its relation to BRCA2 expression remain unexplored. Here, we show that c-kit expression promotes migration and invasion of PCa cells. Alongside, we found that c-kit expression in PCa cells parallels BRCA2 downregulation. Gene rescue experiments with human BRCA2 transgene in c-kit-transfected PCa cells resulted in reduction of c-kit protein expression and migration and invasion, suggesting a functional significance of BRCA2 downregulation by c-kit. The inverse association between c-kit and BRCA2 gene expressions in PCa cells was confirmed using laser capture microdissection in experimental intraosseous tumors and bone metastases of PCa patients. Inhibition of bone-induced c-kit expression in PCa cells transduced with lentiviral short hairpin RNA reduced intraosseous tumor incidence and growth. Overall, our results provide evidence of a novel pathway that links bone-induced c-kit expression in PCa cells to BRCA2 downregulation and supports bone metastasis.

摘要

BRCA2功能丧失会刺激前列腺癌细胞侵袭,并且与前列腺癌患者中更具侵袭性和转移性的肿瘤相关。同时,受体酪氨酸激酶c-kit在前列腺癌患者的骨转移灶中高表达,并且在实验模型中置于骨微环境的前列腺癌细胞中被诱导表达。然而,c-kit对前列腺癌骨内生长的确切需求及其与BRCA2表达的关系仍未得到探索。在此,我们表明c-kit表达促进前列腺癌细胞的迁移和侵袭。此外,我们发现前列腺癌细胞中的c-kit表达与BRCA2下调平行。在转染了c-kit的前列腺癌细胞中用人BRCA2转基因进行基因拯救实验导致c-kit蛋白表达以及迁移和侵袭减少,这表明c-kit下调BRCA2具有功能意义。在前列腺癌患者的实验性骨内肿瘤和骨转移灶中使用激光捕获显微切割证实了前列腺癌细胞中c-kit和BRCA2基因表达之间的负相关。用慢病毒短发夹RNA转导的前列腺癌细胞中骨诱导的c-kit表达的抑制降低了骨内肿瘤的发生率和生长。总体而言,我们的结果提供了一条新途径的证据,该途径将前列腺癌细胞中骨诱导的c-kit表达与BRCA2下调联系起来,并支持骨转移。

相似文献

1
Bone-induced c-kit expression in prostate cancer: a driver of intraosseous tumor growth.骨诱导的c-kit在前列腺癌中的表达:骨内肿瘤生长的驱动因素。
Int J Cancer. 2015 Jan 1;136(1):11-20. doi: 10.1002/ijc.28948. Epub 2014 May 20.
2
Loss of BRCA2 promotes prostate cancer cell invasion through up-regulation of matrix metalloproteinase-9.BRCA2的缺失通过上调基质金属蛋白酶-9促进前列腺癌细胞侵袭。
Cancer Sci. 2008 Mar;99(3):553-63. doi: 10.1111/j.1349-7006.2007.00719.x. Epub 2007 Dec 27.
3
Re: Bone-Induced c-Kit Expression in Prostate Cancer: A Driver of Intraosseous Tumor Growth.关于:前列腺癌中骨诱导的c-Kit表达:骨内肿瘤生长的驱动因素
J Urol. 2015 Jul;194(1):260. doi: 10.1016/j.juro.2015.04.026. Epub 2015 Apr 14.
4
Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.miR-133a-3p 的下调通过激活 PI3K/AKT 信号通路促进前列腺癌骨转移。
J Exp Clin Cancer Res. 2018 Jul 18;37(1):160. doi: 10.1186/s13046-018-0813-4.
5
Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer.长链非编码 RNA ZEB1-AS1 下调通过 miR-342-3p/CUL4B 轴调控 PI3K/AKT/mTOR 信号通路抑制前列腺癌细胞增殖、迁移和侵袭。
Cancer Biother Radiopharm. 2020 Nov;35(9):661-672. doi: 10.1089/cbr.2019.3123. Epub 2020 Apr 9.
6
Impact of E6-associated protein on the proliferation and invasion of prostate cancer cells in bone metastasis.E6相关蛋白对前列腺癌细胞骨转移中增殖和侵袭的影响
Int J Clin Exp Pathol. 2015 Jun 1;8(6):6571-5. eCollection 2015.
7
LRP5 knockdown: effect on prostate cancer invasion growth and skeletal metastasis in vitro and in vivo.LRP5 敲低:对体外和体内前列腺癌侵袭生长和骨骼转移的影响。
Cancer Med. 2013 Oct;2(5):625-35. doi: 10.1002/cam4.111. Epub 2013 Sep 5.
8
Prostate cancer promotes a vicious cycle of bone metastasis progression through inducing osteocytes to secrete GDF15 that stimulates prostate cancer growth and invasion.前列腺癌通过诱导成骨细胞分泌 GDF15 来促进骨转移进展的恶性循环,从而刺激前列腺癌的生长和侵袭。
Oncogene. 2019 Jun;38(23):4540-4559. doi: 10.1038/s41388-019-0736-3. Epub 2019 Feb 12.
9
Sin1 promotes proliferation and invasion of prostate cancer cells by modulating mTORC2-AKT and AR signaling cascades.Sin1 通过调节 mTORC2-AKT 和 AR 信号级联促进前列腺癌细胞的增殖和侵袭。
Life Sci. 2020 May 1;248:117449. doi: 10.1016/j.lfs.2020.117449. Epub 2020 Feb 21.
10
Ligand-dependent EphA7 signaling inhibits prostate tumor growth and progression.配体依赖性 EphA7 信号抑制前列腺肿瘤生长和进展。
Cell Death Dis. 2017 Oct 12;8(10):e3122. doi: 10.1038/cddis.2017.507.

引用本文的文献

1
MYH6 suppresses tumor progression by downregulating KIT expression in human prostate cancer.MYH6 通过下调人前列腺癌细胞中 KIT 的表达来抑制肿瘤进展。
Sci Rep. 2024 Aug 24;14(1):19685. doi: 10.1038/s41598-024-70665-3.
2
Cancer Stemness/Epithelial-Mesenchymal Transition Axis Influences Metastasis and Castration Resistance in Prostate Cancer: Potential Therapeutic Target.肿瘤干细胞特性/上皮间质转化轴影响前列腺癌转移和去势抵抗:潜在的治疗靶点。
Int J Mol Sci. 2022 Nov 29;23(23):14917. doi: 10.3390/ijms232314917.
3
Comparative Pathobiology of Canine and Human Prostate Cancer: State of the Art and Future Directions.

本文引用的文献

1
Putative role of HIF transcriptional activity in melanocytes and melanoma biology.缺氧诱导因子转录活性在黑素细胞和黑色素瘤生物学中的假定作用。
Dermatoendocrinol. 2013 Apr 1;5(2):239-51. doi: 10.4161/derm.22678.
2
Hypoxia, notch signalling, and prostate cancer.缺氧、Notch 信号通路与前列腺癌。
Nat Rev Urol. 2013 Jul;10(7):405-13. doi: 10.1038/nrurol.2013.110. Epub 2013 May 28.
3
Elevated Jagged-1 and Notch-1 expression in high grade and metastatic prostate cancers.Jagged-1 和 Notch-1 在高级别和转移性前列腺癌中的表达升高。
犬类和人类前列腺癌的比较病理生物学:现状与未来方向
Cancers (Basel). 2022 May 31;14(11):2727. doi: 10.3390/cancers14112727.
4
Role and significance of c-KIT receptor tyrosine kinase in cancer: A review.c-KIT 受体酪氨酸激酶在癌症中的作用和意义:综述。
Bosn J Basic Med Sci. 2022 Sep 16;22(5):683-698. doi: 10.17305/bjbms.2021.7399.
5
AKT in Bone Metastasis of Solid Tumors: A Comprehensive Review.AKT在实体瘤骨转移中的作用:综述
Cancers (Basel). 2021 May 11;13(10):2287. doi: 10.3390/cancers13102287.
6
CD117/c-kit defines a prostate CSC-like subpopulation driving progression and TKI resistance.CD117/c-kit 定义了一个前列腺 CSC 样亚群,该亚群驱动疾病进展和 TKI 耐药。
Sci Rep. 2021 Jan 14;11(1):1465. doi: 10.1038/s41598-021-81126-6.
7
Does transrectal ultrasonography-guided biopsy of the prostate lead to possible further metastasis via circulating tumor cells?经直肠超声引导下前列腺活检是否会通过循环肿瘤细胞导致可能的进一步转移?
Turk J Med Sci. 2019 Dec 16;49(6):1701-1706. doi: 10.3906/sag-1904-58.
8
RNAs as Candidate Diagnostic and Prognostic Markers of Prostate Cancer-From Cell Line Models to Liquid Biopsies.RNA作为前列腺癌的候选诊断和预后标志物——从细胞系模型到液体活检
Diagnostics (Basel). 2018 Aug 30;8(3):60. doi: 10.3390/diagnostics8030060.
9
Contributions of Thyroid Hormone to Cancer Metastasis.甲状腺激素在癌症转移中的作用。
Biomedicines. 2018 Aug 22;6(3):89. doi: 10.3390/biomedicines6030089.
10
Integrated bioinformatics analysis reveals that the expression of cathepsin S is associated with lymph node metastasis and poor prognosis in papillary thyroid cancer.整合生物信息学分析显示组织蛋白酶 S 的表达与甲状腺乳头状癌的淋巴结转移和不良预后相关。
Oncol Rep. 2018 Jul;40(1):111-122. doi: 10.3892/or.2018.6428. Epub 2018 May 8.
Am J Transl Res. 2013 Apr 19;5(3):368-78. Print 2013.
4
Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial.卡博替尼治疗晚期前列腺癌患者的疗效:一项 II 期随机停药试验的结果。
J Clin Oncol. 2013 Feb 1;31(4):412-9. doi: 10.1200/JCO.2012.45.0494. Epub 2012 Nov 19.
5
Stem cell factor receptor/c-Kit: from basic science to clinical implications.干细胞因子受体/c-Kit:从基础科学到临床意义。
Physiol Rev. 2012 Oct;92(4):1619-49. doi: 10.1152/physrev.00046.2011.
6
Phase I study investigating the safety and feasibility of combining imatinib mesylate (Gleevec) with sorafenib in patients with refractory castration-resistant prostate cancer.研究甲磺酸伊马替尼(格列卫)联合索拉非尼治疗难治性去势抵抗性前列腺癌的安全性和可行性的 I 期研究。
Br J Cancer. 2012 Aug 7;107(4):592-7. doi: 10.1038/bjc.2012.312. Epub 2012 Jul 17.
7
The role of BRCA1 and BRCA2 in prostate cancer.BRCA1 和 BRCA2 在前列腺癌中的作用。
Asian J Androl. 2012 May;14(3):409-14. doi: 10.1038/aja.2011.150. Epub 2012 Apr 23.
8
Vascular patterning and permeability in prostate cancer models with differing osteogenic properties.具有不同成骨特性的前列腺癌模型中的血管形成和通透性。
NMR Biomed. 2012 Jun;25(6):843-51. doi: 10.1002/nbm.1800. Epub 2011 Dec 2.
9
c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.c-Kit 对于 BRCA1 突变相关乳腺癌的起源细胞的生长和存活是必需的。
Oncogene. 2012 Feb 16;31(7):869-83. doi: 10.1038/onc.2011.289. Epub 2011 Jul 18.
10
Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families.多个乳腺癌家系中 BRCA2 突变男性前列腺癌特异性生存降低。
Cancer Prev Res (Phila). 2011 Jul;4(7):1002-10. doi: 10.1158/1940-6207.CAPR-10-0397.